U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07520162) titled 'A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab' on March 24.
Brief Summary: This is a multicentre, open-label, single-arm, Phase 3b study to assess nasal polyps score and symptoms in Chinese adult participants with chronic rhinosinusitis with nasal polyposis initiating treatment with tezepelumab.
Study Start Date: May 06
Study Type: INTERVENTIONAL
Condition:
Chronic Rhinosinusitis With Nasal Polyps
Intervention:
DRUG: Tezepelumab
At Visit 2 (Week 0), participants who meet the inclusion and exclusion criteria will receive tezepelumab treatment.
All part...